SAD Study of CGB3002 in Healthy Participants

NCT07660341 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer s Disease

Interventions

DRUG: CGB3002 0.08 mg/kg
DRUG: CGB3002 0.4 mg/kg
DRUG: CGB3002 1.2 mg/kg
DRUG: CGB3002 3.6 mg/kg
DRUG: CGB3002 7.2 mg/kg
DRUG: Placebo
DRUG: Comparator Drug

Sponsor

ChainGen Biopharma Ltd

Collaborators

[object Object]